The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3,5-Bis(benzylidene)-1-methyl-4-piperidone ID: ALA515242
PubChem CID: 5386934
Max Phase: Preclinical
Molecular Formula: C20H19NO
Molecular Weight: 289.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1C/C(=C\c2ccccc2)C(=O)/C(=C/c2ccccc2)C1
Standard InChI: InChI=1S/C20H19NO/c1-21-14-18(12-16-8-4-2-5-9-16)20(22)19(15-21)13-17-10-6-3-7-11-17/h2-13H,14-15H2,1H3/b18-12+,19-13+
Standard InChI Key: GHSYIDDDJZZVKM-KLCVKJMQSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
6.4992 -6.8340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2137 -7.2465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9281 -6.8340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9281 -6.0090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2137 -5.5965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4992 -6.0090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2137 -4.7715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4992 -4.3590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4992 -3.5340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7847 -3.1215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2137 -3.1215 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0702 -3.5340 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0702 -4.3590 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7847 -4.7715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7847 -2.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0702 -1.8840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3558 -2.2965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6413 -1.8840 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6413 -1.0590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3558 -0.6465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0702 -1.0590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3558 -4.7715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 11 2 0
8 14 1 0
5 6 2 0
10 12 1 0
6 1 1 0
12 13 1 0
1 2 2 0
13 14 1 0
5 7 1 0
10 15 2 0
3 4 2 0
15 16 1 0
7 8 2 0
16 17 2 0
17 18 1 0
8 9 1 0
18 19 2 0
4 5 1 0
19 20 1 0
9 10 1 0
20 21 2 0
21 16 1 0
2 3 1 0
13 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 289.38Molecular Weight (Monoisotopic): 289.1467AlogP: 3.67#Rotatable Bonds: 2Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.38CX LogP: 4.28CX LogD: 4.28Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.79Np Likeness Score: -0.26
References 1. Pati HN, Das U, Das S, Bandy B, De Clercq E, Balzarini J, Kawase M, Sakagami H, Quail JW, Stables JP, Dimmock JR.. (2009) The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones., 44 (1): [PMID:18468733 ] [10.1016/j.ejmech.2008.03.015 ] 2. Antonova-Koch Y, Meister S, Abraham M, Luth MR, Ottilie S, Lukens AK, Sakata-Kato T, Vanaerschot M, Owen E, Jado JC, Maher SP, Calla J, Plouffe D, Zhong Y, Chen K, Chaumeau V, Conway AJ, McNamara CW, Ibanez M, Gagaring K, Serrano FN, Eribez K, Taggard CM, Cheung AL, Lincoln C, Ambachew B, Rouillier M, Siegel D, Nosten F, Kyle DE, Gamo FJ, Zhou Y, Llinás M, Fidock DA, Wirth DF, Burrows J, Campo B, Winzeler EA.. (2018) Open-source discovery of chemical leads for next-generation chemoprotective antimalarials., 362 (6419): [PMID:30523084 ] [10.1126/science.aat9446 ]